CN100553614C - 口腔用固体速崩、速溶药物组合物及其片剂的制备方法 - Google Patents
口腔用固体速崩、速溶药物组合物及其片剂的制备方法 Download PDFInfo
- Publication number
- CN100553614C CN100553614C CNB021294607A CN02129460A CN100553614C CN 100553614 C CN100553614 C CN 100553614C CN B021294607 A CNB021294607 A CN B021294607A CN 02129460 A CN02129460 A CN 02129460A CN 100553614 C CN100553614 C CN 100553614C
- Authority
- CN
- China
- Prior art keywords
- oral cavity
- pharmaceutical composition
- tablet
- collapse
- instant pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000000214 mouth Anatomy 0.000 title claims abstract description 37
- 239000007787 solid Substances 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 20
- 239000003814 drug Substances 0.000 claims abstract description 25
- 239000008187 granular material Substances 0.000 claims abstract description 24
- 239000000945 filler Substances 0.000 claims abstract description 14
- 239000011230 binding agent Substances 0.000 claims abstract description 10
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 7
- 239000000314 lubricant Substances 0.000 claims abstract description 7
- 238000000227 grinding Methods 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 15
- 229940079593 drug Drugs 0.000 claims description 13
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 12
- 239000004471 Glycine Substances 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 5
- 230000000873 masking effect Effects 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 238000005550 wet granulation Methods 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 3
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 2
- 229920002101 Chitin Polymers 0.000 claims description 2
- 206010013911 Dysgeusia Diseases 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 239000000783 alginic acid Substances 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 229960001126 alginic acid Drugs 0.000 claims description 2
- 150000004781 alginic acids Chemical class 0.000 claims description 2
- -1 analgesic Substances 0.000 claims description 2
- 230000000202 analgesic effect Effects 0.000 claims description 2
- 230000000954 anitussive effect Effects 0.000 claims description 2
- 230000002456 anti-arthritic effect Effects 0.000 claims description 2
- 230000001387 anti-histamine Effects 0.000 claims description 2
- 230000003276 anti-hypertensive effect Effects 0.000 claims description 2
- 230000000845 anti-microbial effect Effects 0.000 claims description 2
- 230000001754 anti-pyretic effect Effects 0.000 claims description 2
- 239000000739 antihistaminic agent Substances 0.000 claims description 2
- 239000002221 antipyretic Substances 0.000 claims description 2
- 229940124584 antitussives Drugs 0.000 claims description 2
- 239000003443 antiviral agent Substances 0.000 claims description 2
- 230000003115 biocidal effect Effects 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 208000026106 cerebrovascular disease Diseases 0.000 claims description 2
- 239000000812 cholinergic antagonist Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 230000006806 disease prevention Effects 0.000 claims description 2
- 238000007908 dry granulation Methods 0.000 claims description 2
- 230000002526 effect on cardiovascular system Effects 0.000 claims description 2
- 239000003172 expectorant agent Substances 0.000 claims description 2
- 230000003419 expectorant effect Effects 0.000 claims description 2
- 206010025482 malaise Diseases 0.000 claims description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 2
- 230000002048 spasmolytic effect Effects 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 210000002784 stomach Anatomy 0.000 claims description 2
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 claims 1
- 230000035807 sensation Effects 0.000 abstract description 6
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 238000005469 granulation Methods 0.000 abstract description 2
- 230000003179 granulation Effects 0.000 abstract description 2
- 238000002156 mixing Methods 0.000 abstract description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 23
- 238000005516 engineering process Methods 0.000 description 17
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 16
- 239000006186 oral dosage form Substances 0.000 description 11
- 229960005489 paracetamol Drugs 0.000 description 11
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 10
- 239000012729 immediate-release (IR) formulation Substances 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 235000019359 magnesium stearate Nutrition 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 6
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 6
- 239000008108 microcrystalline cellulose Substances 0.000 description 6
- 229940016286 microcrystalline cellulose Drugs 0.000 description 6
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 5
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 5
- 229960003022 amoxicillin Drugs 0.000 description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 description 5
- 238000004132 cross linking Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 5
- 235000019615 sensations Nutrition 0.000 description 5
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 5
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229960004543 anhydrous citric acid Drugs 0.000 description 3
- 239000013583 drug formulation Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- 241000234671 Ananas Species 0.000 description 2
- 235000007119 Ananas comosus Nutrition 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229940085605 saccharin sodium Drugs 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000007968 orange flavor Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- RLBIQVVOMOPOHC-UHFFFAOYSA-N parathion-methyl Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C=C1 RLBIQVVOMOPOHC-UHFFFAOYSA-N 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021294607A CN100553614C (zh) | 2002-08-28 | 2002-08-28 | 口腔用固体速崩、速溶药物组合物及其片剂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021294607A CN100553614C (zh) | 2002-08-28 | 2002-08-28 | 口腔用固体速崩、速溶药物组合物及其片剂的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1395919A CN1395919A (zh) | 2003-02-12 |
CN100553614C true CN100553614C (zh) | 2009-10-28 |
Family
ID=4746257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021294607A Expired - Lifetime CN100553614C (zh) | 2002-08-28 | 2002-08-28 | 口腔用固体速崩、速溶药物组合物及其片剂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100553614C (zh) |
-
2002
- 2002-08-28 CN CNB021294607A patent/CN100553614C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1395919A (zh) | 2003-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2189227C2 (ru) | Быстро распадающиеся прессованные в формах материалы и способ их получения | |
EP2572705B1 (en) | Orodispersible tablets | |
US6475510B1 (en) | Process for manufacturing bite-dispersion tablets | |
CN102772379B (zh) | 多层口溶型片剂 | |
JP4551092B2 (ja) | 口腔内速崩壊性錠剤 | |
CN100393305C (zh) | 孟鲁司特口腔崩解片制剂的制备方法 | |
KR20030094272A (ko) | 구강내 급속 붕괴성 정제 | |
PT1145711E (pt) | Formulação de dosagem oral de dissolução instantânea | |
WO1999018936A1 (fr) | Preparations solides rapidement solubles | |
WO2005037319A1 (ja) | 口腔内速崩壊性錠剤用の組成物 | |
CN101460150A (zh) | 用于口腔崩解片剂的可直接压片复合物 | |
JP2003506399A (ja) | 構造的完全性を有する練薬を作成する手段 | |
JP2000086537A (ja) | 無機化合物糖類組成物、賦形剤、速崩壊性圧縮成型物及びその製造方法 | |
Nandy et al. | An overview on fast dissolving drug delivery system | |
CN101277721B (zh) | 口腔崩解片 | |
RADA et al. | Fast dissolving tablets: waterless patient compliance dosage forms | |
CN101461788B (zh) | 一种间苯三酚口腔崩解片及其制备方法 | |
JP3884056B1 (ja) | 口腔内速崩錠の製造方法 | |
CN100553614C (zh) | 口腔用固体速崩、速溶药物组合物及其片剂的制备方法 | |
CN100450470C (zh) | 口腔内快速崩解片剂及其制备方法 | |
Nasreen et al. | Mouth dissolving tablets-A unique dosage form curtailed for special purpose: a review | |
JPH11116465A (ja) | 迅速溶解性製剤およびその製造法 | |
Kumar et al. | Fast dissolving tablets: patient compliance dosage forms | |
CN1631425A (zh) | 咽炎含化片及其制备方法 | |
JP2005029557A (ja) | 口腔内速崩壊性錠剤およびその製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: NINGBO LIWAH PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: LONGBAI BIOENGINEERING SCIENCE AND TECHNOLOGY CO LTD, TIANJIN CITY Effective date: 20110715 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 300074 4/F, PEOPLE'S ART THEATRE BUILDING, NO. 43, PINGSHAN ROAD, HEXI DISTRICT, TIANJIN CITY TO: 315174 XINLIAN VILLAGE, GAOQIAO TOWN, YINZHOU DISTRICT, NINGBO CITY |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110715 Address after: 315174 Ningbo Yinzhou District Gaoqiao Town New Village Patentee after: NINGBO LIWAH PHARMACEUTICAL Co.,Ltd. Address before: 300074, 4 floor, people's art Theatres Building, 43 Pingshan Road, Tianjin, Hexi District Patentee before: LONGBAI BIOENGINEERING SCIENCE |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20091028 |
|
DD01 | Delivery of document by public notice |
Addressee: Zhang Xinming Document name: Notice of Patent Expiration and Termination |
|
DD01 | Delivery of document by public notice |